These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 11417578)

  • 1. Dopamine D2 receptor and obesity.
    Chen J
    Lancet; 2001 Jun; 357(9271):1883. PubMed ID: 11417577
    [No Abstract]   [Full Text] [Related]  

  • 2. Striatal dopamine D2 receptors in modulation of pain in humans: a review.
    Hagelberg N; Jääskeläinen SK; Martikainen IK; Mansikka H; Forssell H; Scheinin H; Hietala J; Pertovaara A
    Eur J Pharmacol; 2004 Oct; 500(1-3):187-92. PubMed ID: 15464032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum.
    Zhou LW; Zhang SP; Qin ZH; Weiss B
    J Pharmacol Exp Ther; 1994 Feb; 268(2):1015-23. PubMed ID: 8113958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Function of dopamine receptor subtypes in striatum].
    Sasa M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Oct; 14(5):359-64. PubMed ID: 7856332
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of D1 and D2 dopamine receptor agonist and antagonist on parkinsonism in chronic MPTP-treated monkeys.
    Nomoto M; Fukuda T
    Adv Neurol; 1993; 60():119-22. PubMed ID: 8093574
    [No Abstract]   [Full Text] [Related]  

  • 6. Modeling excess striatal D2 receptors in mice.
    Kellendonk C
    Prog Brain Res; 2009; 179():59-65. PubMed ID: 20302818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DA D2 receptors in the ventral striatum: multiple effects or receptor subtypes?
    White FJ; Hu XT; Zhang XF
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Apr; 17(2):91-5. PubMed ID: 9201729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Central dopaminergic receptors and negative symptoms in schizophrenia].
    Martinot JL; Paillere-Martinot ML; Loc'h C; Aubin F; Dao-Castellana MH; Deslauriers AG; Syrota A; Lecrubier Y
    Ann Med Psychol (Paris); 1992; 150(2-3):127-30. PubMed ID: 1343506
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhanced dopamine D2 receptor function in hypothalamus and corpus striatum: their role in liver, plasma and in vitro hepatocyte ALDH regulation in ethanol treated rats.
    Akash KG; Anju TR; Peeyush KT; Paulose CS
    J Biomed Sci; 2008 Sep; 15(5):623-31. PubMed ID: 18536982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia.
    Hirvonen J; van Erp TG; Huttunen J; Någren K; Huttunen M; Aalto S; Lönnqvist J; Kaprio J; Cannon TD; Hietala J
    Psychiatry Res; 2006 Jan; 146(1):13-20. PubMed ID: 16361088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paroxysmal non-kinesigenic dyskinesia: pathophysiological investigations.
    Lombroso CT; Fischman A
    Epileptic Disord; 1999 Sep; 1(3):187-93. PubMed ID: 10937152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for NMDA/D2 receptor-receptor interactions in the rat striatum.
    Micheletti G; Lannes B; Warter JM; Zwiller J
    Adv Neurol; 1993; 60():128-32. PubMed ID: 8380517
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole treatment causes extrapyramidal side effects but not prolactin elevation: a disconnect of the striatal D2 occupancy story: case report.
    Shim JC; You YS; Kelly DL
    J Clin Psychopharmacol; 2008 Jun; 28(3):353-4. PubMed ID: 18480699
    [No Abstract]   [Full Text] [Related]  

  • 15. D2 dopamine receptor antisense oligodeoxynucleotide inhibits the synthesis of a functional pool of D2 dopamine receptors.
    Qin ZH; Zhou LW; Zhang SP; Wang Y; Weiss B
    Mol Pharmacol; 1995 Oct; 48(4):730-7. PubMed ID: 7476901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystonia in ataxia telangiectasia: report of a case with putaminal lesions and decreased striatal [123I]iodobenzamide binding.
    Koepp M; Schelosky L; Cordes I; Cordes M; Poewe W
    Mov Disord; 1994 Jul; 9(4):455-9. PubMed ID: 7969215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease.
    Weeks RA; Piccini P; Harding AE; Brooks DJ
    Ann Neurol; 1996 Jul; 40(1):49-54. PubMed ID: 8687191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent effects of obesity: a neuroplasticity hypothesis.
    Matikainen-Ankney BA; Kravitz AV
    Ann N Y Acad Sci; 2018 Sep; 1428(1):221-239. PubMed ID: 29741270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2 receptor and obesity.
    Atadzhanov M
    Lancet; 2001 Jun; 357(9271):1883. PubMed ID: 11417578
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.